Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs

Showing results (121-130 of 294) with videos related to

Pageof 30
Sort By:
Heart (British Cardiac Society)|March 18, 2020
Lifestyle modification in older versus younger patients with coronary artery diseasePatricia Jepma, Harald T Jorstad, Marjolein Snaterse, et al.
International Journal of Cardiology|August 24, 2022
The prevalence of persistent bacteraemia in patients with a non-staphylococcal infective endocarditis, a retrospective cohort studyThomas W van der Vaart, Marjon Stuifzand, S Matthijs Boekholdt, et al.
Atherosclerosis|March 10, 2009
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 28, 2006
Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesisAnke H E M Klerkx, Karim El Harchaoui, Wim A van der Steeg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2004
IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyS Matthijs Boekholdt, Ron J G Peters, C Erik Hack, et al.
Journal of Lipid Research|November 1, 2006
Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population StudySabine Pinedo, Maud N Vissers, Klaus von Bergmann, et al.
European Heart Journal|March 19, 2014
The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011Kausik K Ray, John J P Kastelein, S Matthijs Boekholdt, et al.
Journal of Clinical Lipidology|March 27, 2019
A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease riskRutger Verbeek, Federico Oldoni, R Preethi Surendran, et al.
The American Journal of Medicine|September 24, 2004
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population studyS Matthijs Boekholdt, Ron J G Peters, Nicholas E Day, et al.
Lancet (London, England)|July 27, 2010
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trialPaul M Ridker, Jacques Genest, S Matthijs Boekholdt, et al.
Pageof 30

Showing results (121-130 of 294) with videos related to

Sort By:
Pageof 30
Heart (British Cardiac Society)|March 18, 2020
Lifestyle modification in older versus younger patients with coronary artery diseasePatricia Jepma, Harald T Jorstad, Marjolein Snaterse, et al.
International Journal of Cardiology|August 24, 2022
The prevalence of persistent bacteraemia in patients with a non-staphylococcal infective endocarditis, a retrospective cohort studyThomas W van der Vaart, Marjon Stuifzand, S Matthijs Boekholdt, et al.
Atherosclerosis|March 10, 2009
HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyBenoit J Arsenault, Isabelle Lemieux, Jean-Pierre Després, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 28, 2006
Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesisAnke H E M Klerkx, Karim El Harchaoui, Wim A van der Steeg, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 5, 2004
IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyS Matthijs Boekholdt, Ron J G Peters, C Erik Hack, et al.
Journal of Lipid Research|November 1, 2006
Plasma levels of plant sterols and the risk of coronary artery disease: the prospective EPIC-Norfolk Population StudySabine Pinedo, Maud N Vissers, Klaus von Bergmann, et al.
European Heart Journal|March 19, 2014
The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011Kausik K Ray, John J P Kastelein, S Matthijs Boekholdt, et al.
Journal of Clinical Lipidology|March 27, 2019
A 3-SNP gene risk score and a metabolic risk score both predict hypertriglyceridemia and cardiovascular disease riskRutger Verbeek, Federico Oldoni, R Preethi Surendran, et al.
The American Journal of Medicine|September 24, 2004
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population studyS Matthijs Boekholdt, Ron J G Peters, Nicholas E Day, et al.
Lancet (London, England)|July 27, 2010
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trialPaul M Ridker, Jacques Genest, S Matthijs Boekholdt, et al.
Pageof 30